Aims, design and methods of the smoking and nicotine dependence awareness and screening (SNICAS) study

International Journal of Methods in Psychiatric Research

Volumn 12, Issue 4, 2003, Pages 208-228

  Muehlig, Stephan ^a   Hoch, Eva ^b   Hoefler, Michael ^b   Pittrow, David ^a   Wittchen, Hans Ulrich ^a,b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Epidemiology; Nicotine dependence; Primary care; Smoking; Smoking cessation

Indexed keywords

NICOTINE;

AWARENESS; CLINICAL EXAMINATION; EXPERIMENTAL DESIGN; FREQUENCY ANALYSIS; HEALTH PRACTITIONER; HUMAN; MOTIVATION; PATIENT ATTITUDE; PRIMARY MEDICAL CARE; QUESTIONNAIRE; REVIEW; SCREENING; SMOKING CESSATION; TOBACCO DEPENDENCE;

ADULT; AGED; AGED, 80 AND OVER; AWARENESS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MOTIVATION; PRIMARY HEALTH CARE; QUESTIONNAIRES; SAMPLING STUDIES; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 0347597864     PISSN: 10498931     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpr.158     Document Type: Review

References (77)

1. Anda RF, Williamson DF, Escobedo LG, Mast EE, Giovino GA, Remington P L. Depression and the dynamics of smoking: a national perspective. JAMA 1990; 264: 1541-5.
2. Brandon TH. Negative affect as motivation to smoke. Current Directions in Psychological Science 1994; 3: 33-7.
3. Breslau N, Johnson EO. Predicting smoking cessation and major depression in nicotine-dependent smokers. American Journal of Public Health 2000; 90 (7): 1122-7.
4. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders. 4 edn. Washington: American Psychiatric Association, 1994.
5. American Psychiatric Association. Practice guideline for the treatment of patients with nicotine dependence. American Journal of Psychiatry 1996; 153 (suppl. 10): S1-S31.
6. Arbeitskreis Rauchen und Gesundheit: Consensus Statement. Eching/München: ÄARG, 1998.
7. Batra A, Buchkremer G. Raucherentwöhnung mit dem Nikotinpflaster. Zeitschrift für Ärztliche Fortbildung 1995; 89: 505-9.
8. Bellach B-M, Knopf H, Thefeld W. Der Bundes-Gesundheitssurvey 1997/1998. Das Gesundheitswesen 1998; 60 (suppl. 2): S59-S68.
9. Breslau N, Johnson EO, Hiripi E, Kessler R. Nicotine dependence in the United States - prevalence, trends, and smoking persistence. Arch Gen Psychiatry 2001, 58: 810-16.
10. Buchkremer G, Bents H, Horstmann M, Opitz K, Tölle R. Combination of behavioral smoking cessation with transdermal nicotine substitutution. Addictive Behavior 1989; 14: 229-38.
11. Buchkremer G, Minneker E, Block M. Smoking-cessation treatment combining transdermal nicotine substitution with behavioral therapy. Pharmacopsychiatry 1991; 24: 96-102.
12. Bühringer G, Körger C, Küfner H, Lieb R, Schütz C, Soyka M, Wittchen H-U. Suchtforschungsverbund ASAT: Entwicklung von Zuordnungsmodellen für Interventionen bei Substanzstörungen. Sucht 2002; 48 (3): 200-8.
13. Bundesgesundheitssurvey 1997/1998. Das Gesundheitswesen, Schwerpunktheft 1998, Stuttgart: Thieme, 1998, 60 (suppl 2).
14. Colby SM, Tiffany ST, Shiffman S, Niaura R. Review: are adolescent smokers dependent on nicotine? A review of the evidence. Drug and Alcohol Dependence 2000, 59 (suppl. 1): 83-95.
15. Cohen D, Barton G. The cost of society of smoking cessation. Thorax 1998; 53 (suppl. 2): S38-S42.
16. Cottler L, Robins LN, Babor T, Helzer J, Towle L, Grant B, Blaine J, Wittchen H-U, Sartorius N, Burke J, Regier D, Tipp J, Altamura AC, Andrews G, Dingemann R, Droux A, Essau CA, Farmer A, Halikas J, Ingebringsten, Issac M, jenkins P, Kuehne GE, Krause J, Lepine PP, Lykepsos G, Maier W, Pull C, Rubio-Stipic M, Sandanger I, Smeets R, Tachini G, Tihram M, Torres de la Miranda C. Cross-cultural reliability and acceptability of the CIDI-core substance abuse and dependence questions. In CN Stefans, AD Rabavilas, CR Soldatos (eds), Psychiatry: A World Perspective. Amsterdam: Excerpta Medica, 1990, pp. 144-52.
17. Cottler L, Robins LN, Grant B, Blaine J, Towle L, Wittchen H-U, Sartorius N, Burke J, Regier D, Hezler J, Janca A. The CIDI-core substance abuse and dependence questions: cross cultural and nosological issues. British Journal of Psychiatry 1991; 159: 653-8.
18. Dennis ML. Integrating research and clinical assessment. Measuring client and program needs and outcomes in a changing service environment. NIDA Resource Center for Health Services Research.
19. De Wit DJ, Aguilar-Gaziola S, Bijl R, Borges G, Caraveo-Anduaga JJ, Kessler RC, Kolody B, Merikangas KR, Molnar BE, Vega WA, Walters EE, Wittchen H-U. Cross-national comparisons of drug use and drug-related problems. Addiction (in press).
20. Etter J-F, Perneger TV. A comparison of two measures of stage of change for smoking cessation. Addiction 1999; 94(12): 1881-9.
21. Fagerström KO, Schneider NG, Lunell E. Effectiveness of nicotine patch and nicotine gum as individual versus combined treatment for tobacco withdrawal symptoms. Psychopharmacology 1993; 111: 271-7.
22. Fagerström KO. Combined use of nicotine replacement products. Health Values 1994; 18: 15-20.
23. Fiore MC, Bailey WC, Cohen SJ, Dorfmann SF, Goldstein HG, Gritz ER, Heyman RB, Holbrook J. Treating tobacco use and dependence. Clinical practice guideline. Rockville MD: U.S. Department of Health and Human Services. Public Health Services, 2000.
24. Fowler G. Smoking cessation: the role of general practitioners, nurses and pharmacists. In CT Bolliger, KO Fagerström (eds) The Tobacco Epidemic. Progress in Respiratory Research. Basel: Karger, 1997, pp. 165-77.
25. Haustein K-O. Pharmacotherapy of nicotine dependence. International Journal of Clinical Pharmacology and Therapeutics 2000; 38: 273-90.
26. Haustein K-O. Tabakabhängigkeit - Gesundheitliche Schäden durch das Rauchen. Köln: Deutscher Ärzte-Verlag, 2001.
27. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction 1991; 86(9): 1119-27.
28. Hurt RD, Sachs DPL, Glower ED, Offord KP, Johnston JA, Dale LC, Khayrallah MA, Schroeder DR, Glover PN, Sullivan CR, Croghan IT, Sullivan PM. A comparison of sustained-release bupropion and placebo for smoking cessation. New England Journal of Medicine 1997; 337: 1195-202.
29. Jäkle C, Keller S, Baum E, Basler H-D. Skalen zur Selbstwirksamkeit und Entscheidungsbalance im Prozess der Verhaltensänderung von Rauchern. Diagnostica 1999; 45(3): 138-46.
30. Jarvis MJ. Patterns and predictors of smoking cessation in the general population. In CT Bolliger, KO Fagerström (eds) The Tobacco Epidemic. Progress in Respiratory Research. Basel: Karger, 1997, pp. 115-64.
31. John U, Hanke M. Tabakrauch-attributable Mortalität in deutschen Bundesländern. Gesundheitswesen 2001; 63: 363-9.
32. Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, Smith SS, Muramoto ML, Daughton DM, Doan K, Fiore MC, Baker TB. A controlled trial of sustained-release Bupropion, a nicotine patch, or both for smoking cessation. The New England Journal of Medicine 1999; 340: 685-91.
33. Junge B, Nagel M: Das Rauchverhalten in Deutschland. Gesundheitswesen 1999; 61 (suppl. 2): 121-5.
34. Junge B, Thamm M. Jahrbuch Sucht 2003, Tabak - Zahlen und Fakten zum Konsum. Geesthacht: Neuland-Verlag, 2001, pp. 34-61.
35. Krause P, Wittchen H-U, Höfler M, Winter S, Spiegel B, Pfister H. Generalisierte Angst und Depression in der Allgemeinarztpraxis (GAD-P). Studiendesign und Methodik. MMW Fortschritte der Medizin 2001; 119 (suppl. 1): 5-12.
36. Krause, P, Wittchen H-U, Küpper B, Sharma AM, Ritz E, Göke B, Lehnert H, Unger T, Kirch W, Pittrow D, Tschöpe, D. The Hypertension and Diabetes Screening and Awareness Study (HYDRA): aims, design and methods of an innovative epidemiological approach. European Journal of Public Health 2002; 12 (suppl.): 70.
37. Lachner G, Wittchen H-U, Perkonigg A, Holly A, Schuster P, Wunderlich U, Türk D, Garczynski E, Pfister H. Structure, content and reliability of the Munich-Composite International Diagnostic Interview (M-CIDI). Substance use sections. European Addiction Research 1998; 4(1-2): 28-41.
38. Lachner G, Wittchen H-U. Das Composite International Diagnostic Interview Substance Abuse Module (CIDI-SAM). In K Mann, G Buchkremer (eds) Sucht. Grundlagen, Diagnostik, Therapie. Stuttgart: Gustav Fischer, 1996, pp. 147-56.
39. Lieb RB, Isensee B, Von Sydow K, Wittchen H-U. The Early Developmental Stages of Psychopathology Study (EDSP): a methodological update. European Addiction Research 2000; 6(4): 170-82.
40. Lieb R, Schuster P, Pfister H, Fuetsch M, Höfler M, Isensee B, Müller N, Sonntag H, Wittchen H-U. Epidemiologie des Konsums, Mißbrauchs und der Abhängigkeit von legalen und illegalen Drogen bei Jugendlichen und jungen Erwachsenen: Die prospektiv-longitudinale Verlaufsstudie EDSP. Sucht 2000; 46(1): 18-31.
41. Loddenkemper R, Sybrecht GW. Health care costs of smoking. European Respiratory Journal 2000; 16: 377-8.
42. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 1997; 349: 1269.
43. Nelson CB, Wittchen H-U. Smoking and nicotine dependence: Results from a sample of 14 to 24 year olds in Germany. European Addiction Research 1998a; 4(1-2): 42-9.
44. Nelson CB, Wittchen H-U. Editorial: The EDSP: Setting the Stage! European Addiction Research 1998b; 4 (1-2): 5-7.
45. Perkonigg A, Lieb R, Wittchen H-U. Substance use, abuse and dependence in Germany: a review of selected epidemiological data. European Addiction Research 1998; 4(1-2): 8-17.
46. Pierce JP, Fiore MC, Novotny TE, Hatziandreu EJ, Davis RM. Trends in cigarette smoking in the US: projections to the year 2000. JAMA 1989, 261: 61-5.
47. Prochaska JO, DiClemente CC. The transtheoretical approach. In Norcross JC, Goldfried MR (eds) Handbook of Psychotherapy Integration. New York: Basic Books, 1992.
48. Prochaska JO, DiClemente CC, Velicer WF, Rossi JS. Standardized, individualized, interactive, and personalized self-help programs for smoking cessation. Health Psychology 1993; 12: 399-405.
49. Ruff LK, Volmer T, Nowak D, Meyer A. The economic impact of smoking in Germany. European Respiratory Journal 2000; 16 : 385-90.
50. Samet JH, Larson MJ, Horton NJ, Doyle K, Winter M, Saitz R. Linking alcohol-and drug-dependent adults to primary medical care: a randomized controlled trial of a multi-disciplinary health intervention in a detoxification unit. Addiction 2003; 98 (4): 509-16.
51. Schön S, Nowak D. Medikamentöse Verfahren zur Raucherentwöhnung. Suchtmedizin in Forschung und Praxis 2002; 3 (suppl.).
52. Silagy C, Mant D, Fowler G, Lodge M. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 1994; 343: 139-42.
53. Sonntag H. Epidemiologie des Rauchens und der Nikotinabhängigkeit bei Adoleszenten und jungen Erwachsenen - Eine 5-Jahres prospektiv-longitudinale Entwicklungsstudie an 3021 Personen aus der Allgemeinbevölkerung. Dissertation, München, 2001.
54. Sonntag H, Hoch E, Jahn B, Spiegel B, Pfister H, Wittchen H-U. Tabakentwöhnungsmaßnahmen in der allgemeinärztlichen Versorgung: Implementrerung, Effektivität und Wege einer optimierten Allokation. Suchtmedizin in Forschung und Prakis 2003, 5: 137-41.
55. Sonntag H, Kröger C, Shaw R. Setting up an information system on smoking cessation programmes. IFT Berichte. Band Nr. 96. München: IFT Institut für Therapieforschung, 1998.
56. Sonntag H, Pfister H, Wittchen H-U. Rauchen und Nikotinabhängigkeit in Deutschland. Ergebnisse des bundesweiten Zusatz-Surveys, Psychische Störungen' im Rahmen des Bundes-Gesundheitssurveys, 1998.
57. Sonntag H, Wittchen H-U, Höfler M, Kessler RC, Stein MB. Are social fears and DSM-IV social anxiety disorder associated with smoking and nicotine dependence in adolescents and young adults? European Psychiatry 2000; 15 (1): 67-74.
58. US Department of Health and Human Services. People Health: National Health Promotion and Disease Prevention Objectives. Full Report. Washington: Department of Health and Human Services, 1990.
59. Üstün TB, Wittchen H-U. Instruments for the assessment of substance use disorders. Current Opinion in Psychiatry 1992; 5: 412-19.
60. Welte R, König HH, Leidl R. The costs of health damage and productivity losses attributable to cigarette smoking in Germany. Eur J Public Health 2000;10: 31-8.
61. Winter S, Wittchen H-U, Höfler M, Spiegel B, Ormel H, Müller N, Pfister H. Design und Methoden der Studie 'Depression 2000'. MMW Fortschritte der Medizin 2000; 118 (suppl. 1): 11-21.
62. Wittchen H-U (ed). Depression 2000. Eine bundesweite Depressions-Screening-Studie in Allgemeinarztpraxen. MMW Fortschritte der Medizin 2000; 118 (suppl. I/2000).
63. Wittchen H-U (ed.) NISAS 2000: Die Nationwide Insomnia Screening and Awareness Study (NISAS). Prävalenz und Verschreibungsverhalten in der allgemeinärztlichen Versorgung. MMW Fortschritte der Medizin 2001; 119 (suppl. I/2001).
64. Wittchen H-U (ed.) GAD-P-Studie. Bundesweite Studie 'Generalisierte Angst und Depression im primärärztlichen Bereich'. MMW Fortschritte der Medizin 2001; 119, (suppl I/2001).
65. Wittchen H-U (ed). Die Hypertension and Diabethes Awareness and Screening-(HYDRA)-Studie GAD-P-Studie. Bundesweite Studie 'Generalisierte Angst und Depression im primärärztlichen Bereich'. MMW Fortschritte der Medizin 2003; 121 (suppl I/2003).
66. Wittchen H-U, Höfler M, Krause P, Riemann D. The Nationwide Insomnia Screening and Awareness Study (NISAS): Aims, methods and first findings. Abstract P.21.24. International Journal of Neuropsychopharmacology 2000; 3 (suppl. 1): 392.
67. Wittchen H-U, Höfler M, Meister W. Prevalence and recognition of depressive syndromes in German primary care settings: poorly recognized and treated? International Clinical Psychopharmacology 2001; 16 (3): 121-35.
68. Wittchen H-U, Krause P, Höfler M, Winter S, Spiegel B, Hajak G, Riemann D, Pittrow D, Steiger A, Pfister H. NISAS-2000 - die Nationale Insomnie Awareness und Screening Studie. Insomnien und Schlafstörungen in der allgemeinärztlichen Versorgung. Nervenheilkunde 2001b; 20 (1): 4-16.
69. Wittchen HU, Nelson CB. Early developmental stages of substance abuse. European Addiction Research 1998; 4: 1-84.
70. Wittchen H-U, Perkonigg A, Lachner G, Nelson C B. Early developmental stages of psychopathology study (EDSP) - objectives and design. European Addiction Research 1998; 4 (1-2): 18-27.
71. Wittchen H-U, Pfister H (eds) DIA-X-Interviews: Manual für Screening-Verfahren und Interview. Frankfurt: Swets & Zeitlinger, 1997.
72. Wittchen H-U, Schuster P, Pfister, H, Müller N, Storz S, Isensee B. Depressionen in der Allgemeinbevölkerungschlecht erkannt und selten behandelt. Nervenheilkunde 1999; 18: 202-9.
73. Wittchen H-U, Sonntag H, Nowak D, Kröger C, Schmidt LG. Raucherentwöhnung beim Hausarzt -Illusion oder Perspektive? Der Hausarzt 2002; 6: 49-53.
74. World Health Organization (WHO). The Composite International Diagnostic Interview (CIDI). Geneva: World Health Organization, Division of Mental Health, 1990.
75. World Health Organization (WHO). Tobacco or health: a global status report. Geneva: World Health Organization, 1997.
76. World Health Organization (WHO). Gemeinsam handeln - Tabakkonsum reduzieren: Dokumentation der Abschlusskonferenz des WHO-Partnerschaftsprojektes Tabakabhängigkeit (1999-2002). WHO-Konferenzband. pdf in: www.1who-nichtrauchertag.de, 2002.
77. Zimmer D, Lindinger P, Mitschele U. Neue Wege in der verhaltenstherapeutischen Behandlung des Rauchens. Verhaltenstherapie 1993; 3: 304-11.